thank for us and you, joining everyone Thank Trevor. Good you afternoon today.
Strong once large cash profitability we million was our the and results continued million, newer as offering well driven the $XXX.X generate grew monthly strong by quarter offerings. business $XXX.X for and the unit year-over-year growth year-over-year XX% revenue Prescription our combination unique operating fourth growing by quarter Our prescription to increase driven which ability market our transactions as XX% in our highlight Revenue and provides. in active XX% in year-over-year again our a to consumers. growth scale, of economics, operate execute flow.
on manufacturer our of As does the a offerings the reminder, given active quarter. our the GoodRx use as unique prescription monthly calendar month. And monthly and active for consumers their represent consumers, in a in average other not the who represent the save to telehealth. When subscriptions, number consumers solutions presented it include consumers months of of quarter, such
latter a from the reached that quarter. in XXXXs count MAC X.X third was mid-XXXs in Our quarter, which million MACs of a included of Scriptcycle. Scriptcycle small record acquisition of the the closed part
quarter first the was count. MACs the quarter have in fourth the included that been to related So Scriptcycle
provide, roughly has at GoodRx lower Scriptcycle, same included is significantly MACs. in revenue that continue increases revenue our consumer incremental user per organic large whose and MACs prescription to grow in has rate GoodRx We contribution use other further potential MACs than to transactions its expect reach to however, and the consumers represent our our revenue offerings the Scriptcycle future. Scriptcycle a as group
entry these in over growth consistent. multiple as offerings. consumer with our our offerings grows value remained they largely time. ability XXX% which newer growth to to growing our as create into platform, economics year-over-year The $XX.X the well all Scriptcycle, strong million Excluding points other LTV our Other bring revenue to have grew reflects of consumers of
approximately provide base more the a of consumer millions the on view count subscriber growing As way visitors Trevor to another this mentioned, disclosing our with to portion We're platform. XXX,XXX of subscribers. present monetize holistic quarter our we finished and year we a our of
even and which offering a business, same often scale become prescription offer transactions having us our LTV through And more better active successful subscription revenue predictability. consumer consumers It go natural of we on the same Many offerings, savings addresses becoming we generally and they when Our a funnel our times, needs extension ever is prescription for choose offers consumer. prices. through beneficial the higher rapidly prescription is medications. the searching offering. a because believe been consumers will without subscribers is subscription This that mutually and they also for they price, lowest if generate monthly provide value greater
subscription financials, X.X XXX,XXX MACs prescription increased XX As subscribers visitors to we could conversion prescription-related million scale and we it January. To looking continue offering and offerings, our offering. higher see to LTV. meaningfully offering, our in GoodRx total in from in contributes our MACs also to which million our our produces a we have has more monthly also transactions summarize, at subscription
In value prescription these such portion of addition solutions, increasing MACs to as monetizing to to we're offerings. our able the monetize and related a visitors further with subscribers, manufacturer offerings of scale and more delivering consumers
our back transactions partially performance, quarter to was in and by subscriptions Turning the COVID-XX. of headwinds prescription to offset our offering growth the XQ related
widespread surgeon physician therapy and new consumers restrictions, defer volume the coupled an with the lockdowns quarter. season cold resulting fourth With This non-urgent continue prescription and cases impacted to and starts unusually flu visits. negatively in weak and
As built health the backlog rebound prescription are and doctor visits, new care year. capitalize once therapy resumed we last starts we substantial purchases over the to Trevor well-positioned start that mentioned, typical in and fills up clearing on believe has consumers the
support outsourced increase and in in growth offerings provider increase to in-house and allocations. of provider XXXX. to number is was our X% personnel in to $X.X $X.X compared an to million overhead by Moving the and increase down of due million online or an our driven the X.X% related XQ revenue revenue consumer related costs The P&L, cost support increase expense visits revenue telehealth and of of in
to deliver mid-XXs We primarily $XX.X to in at Product gross an in strong due and based continued comparable connection million our last technology This period year. development expenses compensation, to made stock in team the and compared increase were continue as as $X.X increases the well levels. IPO. awards product in million including margins the investment with
Excluding stock-based continuing with X.X% the consumer compared XXXX. to expense platform and offerings. experience, product plan invest technology was scale and of new continue acquisitions, in to revenue offerings our compensation in revenue adjusted XX.X% development to developing and We creating various of items product XQ goal to to related our the of best and existing
are expense, strong in stages with revenue base of XXXX. team consumers build value All to $XX.X which year. We as Adjusted we their more deliver consumer long-term. a and returns by and in percent intended journey, year-over-year lifetime our last spend of yield million us brand, building to a a and XQ and advertising increasing increased of were increase in will marketing XQ the XX.X% GoodRx believe to healthcare sales continued the them compared The making help expenses and we different of compared sales marketing more million to a $XX.X million to XXXX which lower $XX.X generate. XX.X% value positive for goal was modestly of year-over-year, revenue
optimize made and health, earlier visits $XXX.X the with to was of new payroll of million, majority endeavor the $XXX.X due described million expenses of market to actively well non-cash stock I've a IPO, approximately stock-based compared The GoodRx and as XX% continue related were are associated $X.X charge donation in that the conditions a monitoring our awards of as in XXXX. call. to expense charitable non-recurring and $XX.X this philanthropic tax Co-CEO increase or doctor million connection We starts. expense therapy light support non-recurring in related to of COVID-XX compensation this to million General in spending quarter in acquisition fourth consumer and administrative
our a adjusted these a of XQ quarter, the XXXX to G&A is to a percent $XXX.X of million at the XX% compared non-recurring million payroll taxes XX%, XQ Co-CEO grants and stock the X.X% Adjusted non-recurring related at IPO Adjusted XXXX. made in continued the which loss incremental Excluding other million. platform, compelling non-recurring $XX.X EBITDA growing of two starting $XXX.X September. strong to and our million Adjusted related at to $XX.X a to to of remained donation. compensation profitable the due unrelated this $XXX.X as as costs XX%. based to at year-over-year fourth the stock end business of quarter, associated revenue due compared incurred public XX% $XX.X with million ability margin growth to items, net was the and unit our net of in EBITDA repeat and income be is in $XX we to deliver operate primarily million. to company In with the on million economics of over time which expense reflecting X.X% activity primarily grew Again,
and XXX third margin EBITDA a EBITDA in due technology. advertising basis all and the fourth quarter and investments product our increase discussed. to of approximately points an our I've earnings of quarter, decreased some year-over-due primarily infrastructure, Our On the a margin telehealth during The growth to quarter-over-quarter shift in investments third development administrative discussed from investments of basis, into spend adjusted in continued general our business quarter call. as adjusted and marketing which decreased
some related as we We Co-CEO by flow from well XXXX our activities tax payroll to million continued marketing had for relation prepaid the company was impacted as operating operation to Cash public as quarter. some a expense flow activities with expenses make in expense. cash generate flow to for over of the operating cash grant, net million in $XX.X to strong from and $XX
We million year and been $XXX statement the investments headquarters net capital fourth amount reimbursement, with headquarters, million the in under have new of to while cash our which limited equivalents. primary quarter There to completed quarter, build of the ended tenant of the be cash we were our date Santa in Approximately first additional On may spent platform some spent as of improvement million and well construction. substantially was as the new $X Monica, cash product. CapEx the investment our flow to related XXXX. our front, investments of non-recurring in $XX of in continue hitting approximately one-time our
guidance, spend to I want to on turning Co-CEO awards. the Before a moment
at the we for of to on time As a our performance-based the approximately million price XX.X Co vesting granted four years. other and shares, portion equity million million of of awards our dependent of over the expense. performance-based expense; non-recurring a total with A and total reminder, of expense IPO, shares portion CEOs $XXX portion million were time-based. awards $XXX the was of $XXX time-based The the the of portion totals
As of expensed the million end of of $XX has been and XXXX, the quarter $XXX quarter. and million, the at in performance-based fourth award third in portion million the fully $XXX vested the
period. the XXXX, first time the future be in were next million, respectively and the quarter expensed third $XX awards of $XX in quarter in $XXX the million in the $XX $XX in will For million be to the XXXX; of million starting Approximately million, quarter. quarters based and expensed million $XX expensed remaining $XXX fourth $XX four in leaving million remaining million portion, $XX the million million $XX in
In addition with to awards. tax stock in fourth $XX.X based million connection in compensation these we quarter incurred the of employer expense also
as revenue offerings year-over-year growth XX% million, be momentum solutions, triple and primarily taxes now turning of couple incurred in $XXX reflecting believe to $XX telehealth the midpoint. our million XXXX We continues. manufacturer digit for driven of in or million revenue this the subscriptions million. We XXXX expect X.X% be at we expect the another other will of dollars employer $XXX by first growth quarter of to approximately guidance; in increase a And to
for in We estimate that quarter quarter to We have transactions have a of this expect this the worth to the cold On will impact headwinds COVID-XX the transactions COVID and vast approximately flu with quarter well. growth that reflected to first quarter the revenue impacted the our $X season revenue a and continued felt as of impact winter relative QX contribute and lack the related comparative extremely flu strong year-over-year majority into prescription first Fourth with noting it's million guidance. of XXXX quarter an first a in negative QX basis, to are prescription XXXX. us of our on week total XXXX.
non-pandemic the that of last in strong, the environment a seasonally was year quarter case typically first and The year. is
Additionally, stockpiled we of pull saw the forward last their some medications. pandemic onset as consumers at March the modest
revenue to our make continue quarter. We of expect the other to figure revenue an percentage up in first increasing
the approximately XX% margin brand adjusted we expect adjusted of and an in continue as invest to our platform. EBITDA On we front, EBITDA
As stated and earnings we It's be worth our on quarter's visits providing consumer growth that guidance call, basis. long will in prescriptions, MAC our to and behavior a be regular third COVID-XX user impact specific our not as doctor around around continues count as noting subscriber may impacted.
recent demand, the However, medical help healthcare we are in this reengage backlog which believe and clear A study clearing to from that pent-up continues by to there our IQVIA we this will will with the be X billion happen. tailwinds found system. substantial build. followed be we of the backlog begins that, diagnosis visits XXXX, that see there When to not did consumers almost
$XXX to we to quarter the will growth the and of the a backlog revenue as expect of X COVID-XX be to will healthcare in XXXX by substantial volumes. begin to clear full the assumes the visits pick-up prescription activity to quarter second will billion start third visit impacted year, significantly XX% and at therapy of million, begin adding Turning This reflecting million year-over-year midpoint. still $XXX
we platform right expect to our to of make as our range future brand our the our We foundation and continue of to laying the for XX% to with margin the adjusted XX% our growth company shareholders. in maximize value XXXX investments for and be EBITDA the consumers,
platform, believe cash combination we've Trevor digital investing best opportunity. our and and stakeholders brand for experience access of and that a with relationships focused brand, care that, our I'll all continue consumer a strong only and scratch in growth decade with closing our leading the mover of the massive market building the platform healthcare health This is the a are begun the We U.S. in just strong time consumer creating from of user platform affordability high to a improved to thoughts. Americans. goal experience product, in advantage now scale to profitability. experience, a surface and with all flows in we ecosystem. our turn benefit of We And key first And and benefit for rare
